Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Blood Salvage Therapy During Oncologic Liver Surgeries on Allogenic Transfusion Events, Survival and Recurrence

NCT05164406 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT05164406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05164406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Blood Salvage Therapy During Oncologic Liver Surgeries on Allogenic Transfusion Events, Survival and Recurrence
Lead sponsor
Université de Sherbrooke
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
February 28, 2021
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver neoplasms